Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; the Tiara technology in development for the transcatheter treatment of mitral valve disease; and a line of advanced biological tissue products that are used as key components in various third-party medical products, such as vascular surgical patches and transcatheter heart valves. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products. In addition, it provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, Neovasc Inc. offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is based in Richmond, Canada.

Key Statistics